Statsols Blog

Statsols

Recent Posts by Statsols:

Data Integration and Visualization

Today’s complex clinical trials yield data sets that are almost unimaginably large and complex. As a result, the process of transforming trial data into usable knowledge simply cannot be accomplished using traditional presentation methods such as conventional charts and graphs.

Topics: Industry News

New lung cancer detection instrument moving to clinical trials stage

Owlstone Nanotech, the developers of a promising new lung cancer detection instrument have announced they are now moving their device into clinical trials. The trials are said to begin later this year in a rapid access lung cancer clinic at Glenfield Hospital in Leicester, England.

Topics: News & Events Industry News

Institute of Medicine releases report “Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk”

Great BLOG Post from By ED SILVERMAN on the Wall Street Journal

Topics: Uncategorized

nQuery Advisor + nTerim used to calculate sample size at St James Hospital, Dublin.

nQuery Advisor + nTerim was used to calculate sample size in a study conducted at St James Hospital, Dublin. The study evaluated the dose intensity and toxicities experienced by patients of normal and increased body mass index BMI treated with FOLFOX chemo- therapy, and demonstrated that overweight patients may tolerate doses based on actual body weight.

Topics: News & Events Power & Sample Size

Clinical trials to begin soon for eZMapp, created by Mapp Biopharmaceutical.

The experimental ZMapp treatment created by Mapp Biopharmaceutical will soon begin human clinical trials in the United States and Liberia, following efforts to boost production capacity.

Topics: Industry News

Clinical trial combo started by Amgen and Merck

Combo clinical trial from Amgen and Merck

Amgen and Merck have launched an early-stage clinical trial pairing their respective cancer immunotherapies, looking to confirm the clinical and commercial promise of combination approaches to cancer.

Topics: Uncategorized

Brincidofovir a very-broad-spectrum antiviral drug?

Brincidofovir, or CMX001, is a broad-spectrum antiviral drug in development by Chimerix. The drug is presently in Phase 3 trials for life-threatening adenovirus in children and adults who have compromised immune systems and for adults with cytomegalovirus infections acquired after hematopoietic stem cells transplants for cancer.

Topics: News & Events

Meta Analysis

What is a Meta Analysis?

Meta-analysis is the statistical procedure for combining data from multiple studies. When the treatment effect (or effect size) is consistent from one study to the next, meta-analysis can be used to identify this common effect. When the effect varies from one study to the next, meta-analysis may be used to identify the reason for the variation.

Topics: Uncategorized